US2832685A
(en)
|
1952-05-24 |
1958-04-29 |
Crest Foods Co Inc |
Solubilization of milk proteins
|
GB894095A
(en)
|
1960-02-08 |
1962-04-18 |
Tanaka Shoichi |
A therapeutic device for personal wear
|
US3528960A
(en)
|
1968-10-07 |
1970-09-15 |
Lilly Co Eli |
N-carboxyaroyl insulins
|
US3719655A
(en)
|
1969-12-05 |
1973-03-06 |
Lilly Co Eli |
Process for the crystallization of the ammonium and alkali metal salts in insulin
|
US3950517A
(en)
|
1970-05-08 |
1976-04-13 |
National Research Development Corporation |
Insulin derivatives
|
US3869437A
(en)
|
1970-05-08 |
1975-03-04 |
Nat Res Dev |
Mono-, di, and N{HD A1{B , N{HU B1{B , N{HU B29{B -tri-acylated insulin
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
US4033941A
(en)
|
1975-12-17 |
1977-07-05 |
Eli Lilly And Company |
Process for purifying glucagon
|
GB1492997A
(en)
|
1976-07-21 |
1977-11-23 |
Nat Res Dev |
Insulin derivatives
|
JPS6030650B2
(ja)
|
1979-10-26 |
1985-07-17 |
日本油脂株式会社 |
座薬基剤組成物
|
JPS5767548A
(en)
|
1980-10-14 |
1982-04-24 |
Shionogi & Co Ltd |
Insulin analog and its preparation
|
HU186826B
(en)
|
1982-06-18 |
1985-09-30 |
Richter Gedeon Vegyeszet |
Method and apparatus for analysing of solution samples with high series number
|
EP0112861B1
(de)
|
1982-07-02 |
1988-01-27 |
Jugo-Import-Export-Anstalt |
Innenschalung für rotationssymmetrische Bauten
|
US4839341A
(en)
|
1984-05-29 |
1989-06-13 |
Eli Lilly And Company |
Stabilized insulin formulations
|
DK347086D0
(da)
|
1986-07-21 |
1986-07-21 |
Novo Industri As |
Novel peptides
|
PH25772A
(en)
|
1985-08-30 |
1991-10-18 |
Novo Industri As |
Insulin analogues, process for their preparation
|
US4849227A
(en)
|
1986-03-21 |
1989-07-18 |
Eurasiam Laboratories, Inc. |
Pharmaceutical compositions
|
PH23446A
(en)
|
1986-10-20 |
1989-08-07 |
Novo Industri As |
Peptide preparations
|
US5266310A
(en)
|
1987-09-17 |
1993-11-30 |
Boehringer Ingelheim International Gmbh |
Stabilization of therapeutically active proteins in pharmaceutical preparations
|
JPH01254699A
(ja)
|
1988-04-05 |
1989-10-11 |
Kodama Kk |
インスリン誘導体及びその用途
|
WO1990001038A1
(en)
|
1988-07-20 |
1990-02-08 |
Nordisk Gentofte A/S |
Human insulin analogs and preparations containing them
|
KR0148748B1
(ko)
|
1988-09-16 |
1998-08-17 |
장 크라메르, 한스 루돌프 하우스 |
사이클로스포린을 함유하는 약학조성물
|
DE3844211A1
(de)
|
1988-12-29 |
1990-07-05 |
Hoechst Ag |
Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
|
US5514646A
(en)
|
1989-02-09 |
1996-05-07 |
Chance; Ronald E. |
Insulin analogs modified at position 29 of the B chain
|
AU6417790A
(en)
|
1989-09-22 |
1991-04-18 |
Tsi-Madison Research Institute |
Method and compositions for one-step cryopreservation of embryos
|
AU628674B2
(en)
|
1989-10-19 |
1992-09-17 |
Nippon Oil And Fats Company, Limited |
Polymer complexes of a sugar response type
|
US5179189A
(en)
|
1990-01-19 |
1993-01-12 |
Nova Pharmaceutical Corporation |
Fatty acid terminated polyanhydrides
|
DK45590D0
(pt)
|
1990-02-21 |
1990-02-21 |
Novo Nordisk As |
|
DK155690D0
(da)
|
1990-06-28 |
1990-06-28 |
Novo Nordisk As |
Nye peptider
|
AU8091091A
(en)
|
1990-07-26 |
1992-02-18 |
University Of Iowa Research Foundation, The |
Novel drug delivery systems for proteins and peptides using albumin as a carrier molecule
|
JPH06501003A
(ja)
|
1990-09-13 |
1994-01-27 |
スミスクライン・ビーチャム・コーポレイション |
非水性液状経口懸濁液
|
DK10191D0
(da)
|
1991-01-22 |
1991-01-22 |
Novo Nordisk As |
Hidtil ukendte peptider
|
US5336782A
(en)
|
1991-04-24 |
1994-08-09 |
Kuraray Co., Ltd. |
Long chain carboxylic acid imide ester
|
ES2093269T3
(es)
|
1991-07-26 |
1996-12-16 |
Smithkline Beecham Corp |
Microemulsiones del tipo agua en aceite.
|
US5206219A
(en)
|
1991-11-25 |
1993-04-27 |
Applied Analytical Industries, Inc. |
Oral compositions of proteinaceous medicaments
|
ZA928916B
(en)
|
1991-11-26 |
1994-05-18 |
Lilly Co Eli |
Tri-arginine insulins
|
EP0547544B1
(de)
|
1991-12-18 |
1997-03-12 |
Hoechst Aktiengesellschaft |
Verfahren zur Gewinnung von insulinhaltigen Lösungen
|
AU5171293A
(en)
|
1992-10-14 |
1994-05-09 |
Regents Of The University Of Colorado, The |
Ion-pairing of drugs for improved efficacy and delivery
|
WO1994008603A1
(en)
|
1992-10-16 |
1994-04-28 |
Smithkline Beecham Corporation |
Compositions
|
JPH08502492A
(ja)
|
1992-10-16 |
1996-03-19 |
スミスクライン・ビーチャム・コーポレイション |
治療用ミクロエマルジョン
|
JPH08507078A
(ja)
|
1993-02-17 |
1996-07-30 |
スミスクライン・ビーチャム・コーポレイション |
治療用ペプチド含有のミクロエマルジョン
|
EP0684833A4
(en)
|
1993-02-17 |
1996-09-11 |
Smithkline Beecham Corp |
MICRO-EMULSIONS COMPRISING THERAPEUTIC PEPTIDES.
|
AU685784B2
(en)
|
1993-02-23 |
1998-01-29 |
Genentech Inc. |
Excipient stabilization of polypeptides treated with organic solvents
|
US5359030A
(en)
|
1993-05-10 |
1994-10-25 |
Protein Delivery, Inc. |
Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
|
US5506203C1
(en)
|
1993-06-24 |
2001-02-06 |
Astra Ab |
Systemic administration of a therapeutic preparation
|
ATE204882T1
(de)
|
1993-09-17 |
2001-09-15 |
Novo Nordisk As |
Acyliertes insulin
|
US6869930B1
(en)
|
1993-09-17 |
2005-03-22 |
Novo Nordisk A/S |
Acylated insulin
|
GB9323588D0
(en)
|
1993-11-16 |
1994-01-05 |
Cortecs Ltd |
Hydrophobic preparation
|
EP1462096B1
(en)
|
1994-03-07 |
2008-12-10 |
Nektar Therapeutics |
Methods and compositions for pulmonary delivery of insulin
|
US6500645B1
(en)
|
1994-06-17 |
2002-12-31 |
Novo Nordisk A/S |
N-terminally extended proteins expressed in yeast
|
US5693609A
(en)
|
1994-11-17 |
1997-12-02 |
Eli Lilly And Company |
Acylated insulin analogs
|
US5646242A
(en)
|
1994-11-17 |
1997-07-08 |
Eli Lilly And Company |
Selective acylation of epsilon-amino groups
|
US6251856B1
(en)
|
1995-03-17 |
2001-06-26 |
Novo Nordisk A/S |
Insulin derivatives
|
CN1196061A
(zh)
|
1995-03-17 |
1998-10-14 |
诺沃挪第克公司 |
胰岛素衍生物
|
US5824638A
(en)
|
1995-05-22 |
1998-10-20 |
Shire Laboratories, Inc. |
Oral insulin delivery
|
US20010041786A1
(en)
|
1995-06-07 |
2001-11-15 |
Mark L. Brader |
Stabilized acylated insulin formulations
|
US20030104981A1
(en)
|
1995-11-03 |
2003-06-05 |
Jelena Mandic |
Human insulin analogues
|
US6451970B1
(en)
|
1996-02-21 |
2002-09-17 |
Novo Nordisk A/S |
Peptide derivatives
|
WO1998001473A1
(en)
|
1996-07-05 |
1998-01-15 |
Novo Nordisk A/S |
Method for the production of precursors of insulin, precursors of insulin analogues, and insulin like peptides
|
EP0938502B1
(en)
|
1996-07-11 |
2004-10-06 |
Novo Nordisk A/S |
Selective acylation method
|
US5981489A
(en)
|
1996-07-18 |
1999-11-09 |
Alza Corporation |
Non-aqueous protic peptide formulations
|
PT821006E
(pt)
|
1996-07-26 |
2004-09-30 |
Aventis Pharma Gmbh |
Derivados de insulina com ligacao a zinco aumentada
|
IL119029A0
(en)
|
1996-08-07 |
1996-11-14 |
Yeda Res & Dev |
Long-acting drugs and pharamaceutical compositions comprising them
|
NZ336900A
(en)
|
1997-01-30 |
2001-06-29 |
Novartis Ag |
Hard gelatine capsules containing pharmaceutical compositions comprising cyclosporin A and being substantially free of any oil
|
US5898067A
(en)
|
1997-02-07 |
1999-04-27 |
Novo Nordisk A/S |
Crystallization of proteins
|
KR20010024556A
(ko)
|
1997-10-24 |
2001-03-26 |
피터 지. 스트링거 |
불용성 인슐린 조성물
|
JP2003525846A
(ja)
|
1997-10-24 |
2003-09-02 |
ノボ ノルディスク アクティーゼルスカブ |
ヒトインスリン誘導体の集合体
|
ZA989744B
(en)
|
1997-10-31 |
2000-04-26 |
Lilly Co Eli |
Method for administering acylated insulin.
|
CA2309818C
(en)
|
1997-11-12 |
2009-05-05 |
Alza Corporation |
Buffered drug formulations for transdermal electrotransport delivery
|
US6531448B1
(en)
|
1997-12-23 |
2003-03-11 |
Eli Lilly And Company |
Insoluble compositions for controlling blood glucose
|
WO1999065941A1
(en)
|
1998-06-12 |
1999-12-23 |
Kings College London |
Insulin analogue
|
GB9814172D0
(en)
|
1998-06-30 |
1998-08-26 |
Andaris Ltd |
Formulation for inhalation
|
PT1107743E
(pt)
|
1998-08-25 |
2007-10-01 |
Advanced Inhalation Res Inc |
Formulações proteicas estáveis secas por pulverização
|
TW570805B
(en)
|
1998-09-01 |
2004-01-11 |
Hoffmann La Roche |
Water-soluble pharmaceutical composition in an ionic complex
|
US7030083B2
(en)
|
1998-09-09 |
2006-04-18 |
University Of Washington |
Treatment of eclampsia and preeclampsia
|
PL197504B1
(pl)
|
1998-10-16 |
2008-04-30 |
Novo Nordisk As |
Trwałe stężone preparaty insulinowe do podawania do płuc
|
US6660715B2
(en)
|
1998-11-19 |
2003-12-09 |
Massachusetts Institute Of Technology |
Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
|
US7425541B2
(en)
|
1998-12-11 |
2008-09-16 |
Medarex, Inc. |
Enzyme-cleavable prodrug compounds
|
ES2180511T3
(es)
|
1999-01-26 |
2003-02-16 |
Lilly Co Eli |
Formulaciones monodispersas de analogos de insulina acilados hexamericos.
|
WO2000047203A1
(en)
|
1999-02-12 |
2000-08-17 |
Mqs, Inc. |
Formulation and system for intra-oral delivery of pharmaceutical agents
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
WO2000061178A1
(en)
|
1999-04-13 |
2000-10-19 |
Inhale Therapeutics Systems, Inc. |
Pulmonary administration of dry powder formulations for treating infertility
|
JP2002543092A
(ja)
|
1999-04-27 |
2002-12-17 |
イーライ・リリー・アンド・カンパニー |
肺投与用インスリン結晶
|
US6309633B1
(en)
|
1999-06-19 |
2001-10-30 |
Nobex Corporation |
Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
|
ES2236010T3
(es)
|
1999-12-16 |
2005-07-16 |
Eli Lilly And Company |
Composiciones de polipeptidos con estabilidad mejorada.
|
CN1141974C
(zh)
|
2000-06-07 |
2004-03-17 |
张昊 |
结肠定位释放的口服生物制剂
|
KR100508695B1
(ko)
|
2001-02-13 |
2005-08-17 |
한국과학기술연구원 |
인슐린의 경구투여용 제형과 그의 제조방법
|
US6867183B2
(en)
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7060675B2
(en)
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
AU2002248464A1
(en)
*
|
2001-02-21 |
2002-09-12 |
Medtronic Minimed, Inc. |
Stabilized insulin formulations
|
CN1160122C
(zh)
|
2001-04-20 |
2004-08-04 |
清华大学 |
一种制备口服胰岛素油相制剂的方法
|
AR033903A1
(es)
|
2001-05-21 |
2004-01-07 |
Inhale Therapeutic Syst |
Una composicion de insulina modificada quimicamente para la administracion pulmonar
|
US6828297B2
(en)
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6858580B2
(en)
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
JP2004537580A
(ja)
|
2001-08-10 |
2004-12-16 |
エピックス メディカル, インコーポレイテッド |
延長された循環半減期を有するポリペプチド結合体
|
US6770625B2
(en)
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
US7030082B2
(en)
|
2001-09-07 |
2006-04-18 |
Nobex Corporation |
Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
|
ATE446971T1
(de)
|
2001-09-07 |
2009-11-15 |
Biocon Ltd |
Verfahren zur synthese von insulinpolypeptid- oligomer-konjugaten und proinsulinpolypeptid- oligomer-konjugaten und verfahren zu deren synthese
|
JP2005526009A
(ja)
|
2001-12-02 |
2005-09-02 |
ノボ ノルディスク アクティーゼルスカブ |
新規グルコース依存性インスリン
|
WO2003047493A2
(en)
|
2001-12-03 |
2003-06-12 |
Dor Biopharma Inc. |
Stabilized reverse micelle compositions and uses thereof
|
AU2002314790A1
(en)
|
2001-12-05 |
2003-06-23 |
Dow Global Technologies Inc. |
Method for immobilizing a biologic in a polyurethane-hydrogel composition, a composition prepared from the method, and biomedical applications
|
KR20040070237A
(ko)
|
2001-12-20 |
2004-08-06 |
일라이 릴리 앤드 캄파니 |
연장된 작용 시간을 갖는 인슐린 분자
|
UA46669C2
(uk)
|
2001-12-29 |
2005-12-15 |
Товариство З Обмеженою Відповідальністю "Мако" |
Спосіб приготування готової лікарської форми інсуліну пролонгованої дії
|
WO2003094956A1
(en)
|
2002-05-07 |
2003-11-20 |
Novo Nordisk A/S |
Soluble formulations comprising monomeric insulin and acylated insulin
|
WO2003094951A1
(en)
|
2002-05-07 |
2003-11-20 |
Novo Nordisk A/S |
Soluble formulations comprising insulin aspart and insulin detemir
|
US7601688B2
(en)
|
2002-06-13 |
2009-10-13 |
Biocon Limited |
Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
|
CN1165549C
(zh)
|
2002-06-15 |
2004-09-08 |
江苏万邦生化医药股份有限公司 |
胰岛素的纯化方法
|
EP1545526A4
(en)
|
2002-09-17 |
2009-09-23 |
Merck & Co Inc |
ELIMINATION OF AN ALDEHYDE IMPURITY IN A REACTIVE POLYSTYRENE RESIN
|
US20040185068A1
(en)
|
2003-03-18 |
2004-09-23 |
Zhi-Jian Yu |
Self-emulsifying compositions, methods of use and preparation
|
ATE529126T1
(de)
|
2003-06-03 |
2011-11-15 |
Novo Nordisk As |
Stabilisierte pharmazeutische peptid zusammensetzungen
|
JP2007524592A
(ja)
|
2003-06-03 |
2007-08-30 |
ノボ・ノルデイスク・エー/エス |
安定化された薬学的ペプチド組成物
|
AU2004247762B2
(en)
|
2003-06-17 |
2010-05-27 |
Sembiosys Genetics Inc. |
Methods for the production of insulin in plants
|
WO2005005477A2
(en)
|
2003-07-11 |
2005-01-20 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
ES2328579T3
(es)
|
2003-07-25 |
2009-11-16 |
Conjuchem Biotechnologies Inc. |
Derivados de insulina de larga duracion y procedimientos asociados.
|
WO2005012347A2
(en)
|
2003-08-05 |
2005-02-10 |
Novo Nordisk A/S |
Novel insulin derivatives
|
ES2445947T3
(es)
|
2003-08-13 |
2014-03-06 |
Biocon Limited |
Formulaciones para dosificación de sólidos de sales de ácidos grasos en forma de micropartículas para agentes terapéuticos
|
US20050118206A1
(en)
|
2003-11-14 |
2005-06-02 |
Luk Andrew S. |
Surfactant-based gel as an injectable, sustained drug delivery vehicle
|
WO2005047508A1
(en)
|
2003-11-14 |
2005-05-26 |
Novo Nordisk A/S |
Processes for making acylated insulin
|
HUE043210T2
(hu)
|
2003-11-20 |
2019-08-28 |
Novo Nordisk As |
Injekciós eszközök elõállítására optimális propilénglikol-tartalmú peptidkészítmények
|
WO2005058961A2
(en)
|
2003-12-12 |
2005-06-30 |
Amgen Inc. |
Antibodies specific for human galanin, and uses thereof
|
DE10358387A1
(de)
|
2003-12-13 |
2005-07-07 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pulver enthaltend niedermolekulares Dextran und Verfahren zu deren Herstellung
|
EP1734938B1
(en)
|
2004-03-26 |
2012-06-20 |
Universita' Degli Studi Di Parma |
Insulin highly respirable microparticles
|
JP2007532629A
(ja)
|
2004-04-15 |
2007-11-15 |
キアスマ, インコーポレイテッド |
生物学的障壁を横切る透過を促進し得る組成物
|
RU2006143544A
(ru)
|
2004-05-10 |
2008-06-20 |
Нэстек Фармасьютикал Кампани Инк. (Us) |
Композиции и способ для облегченной чресслизистой доставки паратиреоидного гормона
|
UA91512C2
(ru)
|
2004-07-19 |
2010-08-10 |
Биокон Лимитед |
Коньюгати олигомеров инсулина, их композиция (варианты) и применение
|
MX2007001589A
(es)
|
2004-08-09 |
2007-08-02 |
Alios Biopharma Inc |
Variantes de polipeptido resistentes a proteasa, hiperglicosiladas sinteticas, formulaciones orales y metodos para utilizar las mismas.
|
DK1791542T3
(en)
|
2004-08-23 |
2015-06-15 |
Mannkind Corp |
Diketopiperazinsalte for pharmaceutical delivery
|
EP1814530A2
(en)
|
2004-09-27 |
2007-08-08 |
Sigmoid Biotechnologies Limited |
Dihydropyrimidine microcapsule-formulations
|
JP2008528549A
(ja)
|
2005-01-27 |
2008-07-31 |
ノボ ノルディスク アクティーゼルスカブ |
構造的に充分に定義された分岐ポリマーと接合されたインスリン誘導体
|
EP1846447B1
(en)
|
2005-02-02 |
2013-08-21 |
Novo Nordisk A/S |
Insulin derivatives
|
EP1846446B1
(en)
|
2005-02-02 |
2013-06-26 |
Novo Nordisk A/S |
Insulin derivatives
|
US20100216690A1
(en)
|
2005-03-18 |
2010-08-26 |
Novo Nordisk A/S |
Pegylated Single-Chain Insulin
|
WO2006103657A2
(en)
|
2005-03-31 |
2006-10-05 |
Dexcel Pharma Technologies Ltd. |
A solid composition for intra-oral delivery of insulin
|
CN101193652B
(zh)
|
2005-04-08 |
2011-11-02 |
安米林药品公司 |
包含肠降血糖素肽和非质子极性溶剂的药物制剂
|
EP1888118B1
(en)
|
2005-05-25 |
2016-08-17 |
Novo Nordisk A/S |
Polypeptide formulations stabilized with ethylenediamine
|
WO2007006320A1
(en)
|
2005-07-12 |
2007-01-18 |
Sherine Hassan Abbas Helmy |
Drinkable oral insulin liquid and capsules
|
WO2007041481A1
(en)
|
2005-09-29 |
2007-04-12 |
Biodel, Inc. |
Rapid acting and prolonged acting insulin preparations
|
CA2626357A1
(en)
|
2005-10-20 |
2007-04-26 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of rapid acting insulin
|
JP4808785B2
(ja)
|
2005-12-28 |
2011-11-02 |
ノボ・ノルデイスク・エー/エス |
インスリン組成物および組成物の製造方法
|
WO2007081824A2
(en)
|
2006-01-06 |
2007-07-19 |
Case Western Reserve University |
Fibrillation resistant proteins
|
JP2009527526A
(ja)
|
2006-02-21 |
2009-07-30 |
ノボ・ノルデイスク・エー/エス |
単鎖インスリンのアナログとその製薬的製剤
|
ES2387955T3
(es)
|
2006-02-27 |
2012-10-04 |
Novo Nordisk A/S |
Derivados de insulina
|
US20090069215A1
(en)
|
2006-03-13 |
2009-03-12 |
Novo Nordisk A/S |
Acylated Single Chain Insulin
|
BRPI0712041A2
(pt)
|
2006-05-09 |
2011-12-27 |
Novo Nordisk As |
derivado de insulina
|
US8796205B2
(en)
|
2006-05-09 |
2014-08-05 |
Novo Nordisk A/S |
Insulin derivative
|
ES2542146T3
(es)
*
|
2006-07-31 |
2015-07-31 |
Novo Nordisk A/S |
Insulinas extendidas PEGiladas.
|
MX2009002999A
(es)
|
2006-09-22 |
2009-04-01 |
Novo Nordisk As |
Analogos de insulina resistentes a proteasa.
|
EP2152243A2
(en)
|
2007-04-30 |
2010-02-17 |
Novo Nordisk A/S |
Highly concentrated insulin solutions and compositions
|
JP2011504871A
(ja)
|
2007-06-01 |
2011-02-17 |
ノボ・ノルデイスク・エー/エス |
固体又は半固体担体中にペプチド薬剤を含む自然に分散可能なプレコンセントレイト
|
EP2514407A1
(en)
|
2007-06-01 |
2012-10-24 |
Novo Nordisk A/S |
Stable non-aqueous pharmaceutical compositions
|
US20100216691A1
(en)
|
2007-07-16 |
2010-08-26 |
Novo Nordisk A/S |
Protease Stabilized, Pegylated Insulin Analogues
|
WO2009022006A1
(en)
|
2007-08-15 |
2009-02-19 |
Novo Nordisk A/S |
Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids
|
US9150633B2
(en)
|
2007-08-15 |
2015-10-06 |
Novo Nordisk A/S |
Insulin analogues with an acyl and alkylene glycol moiety
|
US20090087484A1
(en)
|
2007-09-28 |
2009-04-02 |
Alza Corporation |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
CN101932601B
(zh)
*
|
2007-11-08 |
2016-08-03 |
诺沃-诺迪斯克有限公司 |
胰岛素衍生物
|
WO2009112583A2
(en)
|
2008-03-14 |
2009-09-17 |
Novo Nordisk A/S |
Protease-stabilized insulin analogues
|
AU2009226910B2
(en)
*
|
2008-03-18 |
2014-02-06 |
Novo Nordisk A/S |
Protease stabilized, acylated insulin analogues
|
AU2009309623B9
(en)
|
2008-10-30 |
2014-10-02 |
Novo Nordisk A/S |
Treating diabetes melitus using insulin injections with less than daily injection frequency
|
JP2012510438A
(ja)
|
2008-11-28 |
2012-05-10 |
ノヴォ・ノルディスク・アー/エス |
誘導体化インスリンペプチドの経口投与に適した医薬組成物
|
EP2376531A1
(en)
|
2008-12-09 |
2011-10-19 |
Novo Nordisk A/S |
Novel insulin analogues
|
EP2477644A1
(en)
|
2009-09-16 |
2012-07-25 |
Novo Nordisk A/S |
Stable non-aqueous liquid pharmaceutical compositions comprising an insulin
|
EP2496213B1
(en)
|
2009-11-02 |
2015-08-12 |
Novo Nordisk A/S |
Pharmaceutical solution of non covalently bound albumin and acylated insulin
|
JP5908847B2
(ja)
|
2010-01-12 |
2016-04-26 |
ノヴォ ノルディスク アー/エス |
インスリンペプチドを経口投与するための医薬組成物
|
CN104693302A
(zh)
|
2010-06-23 |
2015-06-10 |
诺沃—诺迪斯克有限公司 |
包含额外的二硫键的胰岛素衍生物
|
WO2012049307A2
(en)
|
2010-10-15 |
2012-04-19 |
Novo Nordisk A/S |
Novel n-terminally modified insulin derivatives
|
US20150111820A1
(en)
|
2012-07-09 |
2015-04-23 |
Novo Nordisk A/S |
Novel use of insulin derivatives
|